{"id":"n_cxeaggv2mk6jarsf5lpq","seq":12358761,"kind":"article","title":"Biocon's Pertuzumab Gets Marketing Authorization in EU, First Biosimilar Approved Under New Tailored Clinical Approach","url":"https://www.equitybulls.com/news/379202/biocon-s-pertuzumab-gets-marketing-authorization-eu-first","published":"2026-11-18T06:23:00Z","seen":"2026-11-18T07:19:04Z","lang":"en","source":{"id":"equitybulls.com","name":"equitybulls.com","domain":"equitybulls.com"},"via":"gdelt-gkg-english","topics":["health","economy"],"authors":["Equity Bulls"],"story":"st_cxeaggv2mk6jarsf5lpq","category":"economy-business","category_p":0.33,"category2":"health","sentiment":"positive","tone":0.35,"political":0.06}